Back to Journals » Infection and Drug Resistance » Volume 10

Pegylated-interferon plus ribavirin treatment does not alter the prevalence of resistance-associated substitutions to direct-acting antivirals in HCV genotype 1a patients

Total article views   Abstract views HTML views PDF downloads Totals
5,992 Dovepress* 4,990 742+ 1,130 5,732
PubMed Central* 0 260 78 260
Totals 4,990 1,002 1,208 5,992
*Since 31 August 2017
+Since July 2016

View citations on PubMed Central and Google Scholar